One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Russia's War in Ukraine and Cardiovascular Health Care.
Parkhomenko, Alexander MD, PhD
doi : 10.1161/CIRCULATIONAHA.122.063196
Volume 147(10) pgs. 779-845,e650-e656 March 07, 2023
Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
Lawal, Oluwadolapo D. PhD, MPH; Aronow, Herbert D. MD; Shobayo, Fisayomi MD; Hume, Anne L. PharmD; Taveira, Tracey H. PharmD; Matson, Kelly L. PharmD; Zhang, Yichi PhD; Wen, Xuerong PhD, MPH
doi : 10.1161/CIRCULATIONAHA.122.060687
The benefit-risk profile of direct oral anticoagulants (DOACs) compared with warfarin, and between DOACs in patients with atrial fibrillation (AF) and chronic liver disease is unclear.
Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease.
Hydes, Theresa J. PhD; Lip, Gregory Y.H. MD; Lane, Deirdre A. PhD
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum.
Essayagh, Benjamin MD; Benfari, Giovanni MD; Antoine, Clemence MD; Grigioni, Francesco MD, PhD; Le Tourneau, Thierry MD, PhD; Roussel, Jean-Christian MD, PhD; Bax, Jeroen J. MD, PhD; Delgado, Victoria MD, PhD; Ajmone Marsan, Nina MD, PhD; van Wijngaarden, Aniek MD; Tribouilloy, Christophe MD, PhD; Rusinaru, Dan MD, PhD; Hochstadt, Aviram MD, MPH; Topilsky, Yan MD; Thapa, Prabin MSc; Michelena, Hector I. MD; Enriquez-Sarano, Maurice MD
doi : 10.1161/CIRCULATIONAHA.122.062612
Mitral valve prolapse (MVP) is responsible for a considerable disease burden but is widely heterogeneous. The lack of a comprehensive prognostic instrument covering the entire MVP spectrum, encompassing the quantified consequent degenerative mitral regurgitation (DMR), hinders clinical management and therapeutic trials.
Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
Friedman, Daniel J. MD; Al-Khatib, Sana M. MD, MHS; Dalgaard, Frederik MD, PhD; Fudim, Marat MD, MHS; Abraham, William T. MD; Cleland, John G.F. MD, PhD; Curtis, Anne B. MD; Gold, Michael R. MD, PhD; Kutyifa, Valentina MD, PhD; Linde, Cecilia MD, PhD; Tang, Anthony S. MD; Ali-Ahmed, Fatima MD; Olivas-Martinez, Antonio MD; Inoue, Lurdes Y.T. PhD; Sanders, Gillian D. PhD
doi : 10.1161/CIRCULATIONAHA.122.062124
Benefit from cardiac resynchronization therapy (CRT) varies by QRS characteristics; individual randomized trials are underpowered to assess benefit for relatively small subgroups.
Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
Bersell, Kevin R. MD, PhD; Yang, Tao PhD; Mosley, Jonathan D. MD, PhD; Glazer, Andrew M. PhD; Hale, Andrew T. PhD; Kryshtal, Dmytro O. PhD; Kim, Kyungsoo PhD; Steimle, Jeffrey D. BS; Brown, Jonathan D. MD; Salem, Joe-Elie MD; Campbell, Courtney C. MD, PhD; Hong, Charles C. MD, PhD; Wells, Quinn S. MD; Johnson, Amanda N. PhD; Short, Laura MS; Blair, Marcia A. MS; Behr, Elijah R. MD; Petropoulou, Evmorfia PhD; Jamshidi, Yalda MD; Benson, Mark D. MD; Keyes, Michelle J. PhD; Ngo, Debby PhD; Vasan, Ramachandran S. PhD; Yang, Qiong PhD; Gerszten, Robert E. MD; Shaffer, Christian MS; Parikh, Shan MD, PhD; Sheng, Quanhu MS; Kannankeril, Prince J. MD; Moskowitz, Ivan P. MD, PhD; York, John D. PhD; Wang, Thomas J. MD; Knollmann, Bjorn C. MD, PhD; Roden, Dan M. MD
doi : 10.1161/CIRCULATIONAHA.122.062193
Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium voltage-gated channel alpha subunit 5) in [almost equal to]20% of subjects.
Collaborative Care Model Helps Patients With Heart Failure Meet End-of-Life Goals.
Kuehn, Bridget M.
Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
Lassen, Mats C. Hojbjerg MD; Modin, Daniel MB; Skaarup, Kristoffer Grundtvig MD; Johansen, Niklas Dyrby MD; Claggett, Brian MS, PhD; Solomon, Scott D. MD; Fralick, Michael MD, PhD; Jensen, Jens Ulrik Staehr MD, PhD; Sivapalan, Pradeesh MD, PhD; Vaduganathan, Muthiah MD, MPH; Pareek, Manan MD, PhD; Schou, Morten MD, PhD; Krause, Tyra Grove MD, PhD; Hviid, Anders DMSc; Kober, Lars MD, DMSc; Torp-Pedersen, Christian MD, DMSc; Gislason, Gunnar MD, PhD; Biering-Sorensen, Tor MD, PhD, MPH, MSc
Effects on Patients of Continuous Eligibility for Medicaid Coverage: Lessons Learned and Lessons to Be Learned From the Pandemic.
Churchwell, Keith MD; O'Malley, Erin JD
Letter by Donzelli Regarding Article, "Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex".
Donzelli, Alberto MD
Response by Mills et al Regarding Article, "Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex".
Mills, Nicholas L. MBChB; Patone, Martina PhD; Hippisley-Cox, Julia MBChB, MD
